Trials / Completed
CompletedNCT00259077
Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
A Double-blind, Randomised, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy of Omeprazole 20mg and 10mg od for the Four-week Treatment of Non-erosive Reflux Disease (NERD) With That of Placebo od and to Investigate Safety
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 270 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study safety and efficacy of omeprazole standard treatment in a Japanese non-erosive reflux disease population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omeprazole |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2005-11-29
- Last updated
- 2011-01-24
Locations
26 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00259077. Inclusion in this directory is not an endorsement.